Dr. Sahin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Av
CLSB 14073
Boston, MA 02115Phone+1 617-919-6258Fax+1 617-730-0284
Summary
- Dr. Mustafa Sahin is a Child Neurologist in Boston, MA and is affiliated with Boston Children's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 22 years. He is experienced in tuberous sclerosis, autism spectrum disorders, and neurogenetics.
Education & Training
- Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1997 - 2000
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1995 - 1997
- Yale School of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- Elected Member National Academy of Medicine, 2023
- The 2018 Philip R. Dodge Lecture Washington University, St Louis MO, 2018
- The Jacob’s Ladder Norman Saunders International Research Prize Hospital for Sick Children, Toronto, Canada, 2017
- Join now to see all
Clinical Trials
- Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2011 Jan 01
- A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
- Treatment of Rett Syndrome With Recombinant Human IGF-1 Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Combining Off-flow, a Nextflow-coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs.Carole Shum, Sang Yeon Han, Bhooma Thiruvahindrapuram, Zhuozhi Wang, Jill de Rijke
Computational and Structural Biotechnology Journal. 2024-12-01 - 1 citationsQuantifying neurobehavioral profiles across neurodevelopmental genetic syndromes and idiopathic neurodevelopmental disorders.Thomas W Frazier, Robyn M Busch, Patricia Klaas, Katherine Lachlan, Eva Loth
Developmental Medicine and Child Neurology. 2024-11-11 - Survey of the Landscape of Society Practice Guidelines for Genetic Testing of Neurodevelopmental Disorders.Siddharth Srivastava, Jordan J Cole, Julie S Cohen, Maya Chopra, Hadley Stevens Smith
Annals of Neurology. 2024-11-01
Press Mentions
- Disrupted Cell Skeletons May Explain Brain Wiring Changes in Autism-Linked ConditionJune 28th, 2021
- A Randomized Double-Blind Controlled Trial of Everolimus in Individuals with PTEN Mutations: Study Design and Statistical ConsiderationsFebruary 6th, 2021
- Earlier Treatment Could Help Reverse Autistic-like Behavior in Tuberous SclerosisOctober 10th, 2018
- Join now to see all
Professional Memberships
- Member
- Child Neurology SocietyMember
- Society for NeuroscienceMember
- American Neurological AssociationMember
- INSARMember
External Links
- HMShttp://www.hms.harvard.edu/dms/bbs/fac/Sahin.php
- Lab Websitehttp://sahin-lab.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: